6 completed, 1 withdrawn. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Withdrawn 1 |
Follow Treatment Interruption: new trials by email Literature Review of Treatment Interruption trials Research Report on Treatment Interruption
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Antiretroviral Activity of 3BNC117 3BNC117, Antiretroviral Treatment Interruption - HIV-1 Infection | Phase 2 | Completed | Rockefeller University | 17 | 2015-10-01 | 2021-06-16 |
| 3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption 3BNC117, ART Interruption - HIV-1 Infection | Phase 2 | Completed | Rockefeller University | 16 | 2015-03-11 | 2020-07-23 |
| Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma Trabectedin, Drug: holiday - Soft Tissue Sarcoma, Uterine Sarcoma | Phase 2 | Completed | Centre Oscar Lambret | 53 | 2011-02-01 | 2026-03-16 |
| Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults Structured treatment interruption - HIV Infections | Phase 2 | Completed | ANRS, Emerging Infectious Diseases | 45 | 2009-05-01 | 2026-04-07 |
| Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx Interleukin 2, HAART, Treatment interruption - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 148 | 2003-10-01 | 2010-10-05 |
| A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body Treatment Interruption - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2008-07-30 | |
| Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV HIV-1 Immunogen, Structured Treatment Interruption - HIV Infections | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-01 |
HIV Infections (4) · Sarcoma (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Rockefeller University (2) · ANRS, Emerging Infectious Diseases (1) · Centre Oscar Lambret (1)
United States (4) · France (3)
Marina Caskey, MD (2) · David Haas (1) · Fred Valentine (1) · Irini Sereti, MD (1)
PMID 25680558, PMID 26568566, PMID 38819800
2008 (1), U01AI118536 (1)